Wipfli Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Wipfli Financial Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$500K	Buy	+6,049	New	+$582K	0.04%	222

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wipfli Financial Advisors's EW Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Edwards Lifesciences (EW) in Q3 2022: 6,049 shares worth $500K. The stake represents 0.04% of the portfolio and ranks #222 among its holdings.

1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Wipfli Financial Advisors held 6,049 shares of Edwards Lifesciences worth $500K as of Q3 2022.
Edwards Lifesciences was a new Wipfli Financial Advisors position in Q3 2022.
Edwards Lifesciences made up 0.04% of Wipfli Financial Advisors's portfolio in Q3 2022, its #222 holding.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.